Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment has closed. The history also shows a new revision (v3.6.0) to the record, following the previous v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedA new revision entry, v3.5.5, was added to the history, replacing the prior v3.5.4.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page footer revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe history now includes a new revision entry labeled v3.5.3 and removes the previous v3.5.2, indicating the record has been updated to a newer version.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the record history.SummaryDifference0.0%

- Check100 days agoChange DetectedAdded revision: v3.5.0 to the history and removed revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.